PAYAL KHANNA: Open Payments
NPI 1679960009 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 43 payments from 12 companies in 2025. Trend: 2023 $1,298 · 2024 $1,034 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $276 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $201 |
| Neurocrine BioSciences, Inc. | 5 | $125 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Lundbeck LLC | 2 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $56 |
| Almatica Pharma LLC | 2 | $30 |
| ABBVIE INC. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: CAPLYTA, TRINTELLIX, REXULTI, INGREZZA, SPRAVATO, LOREEV XR, VRAYLAR, Qelbree.
Industry payments across NC — which companies pay providers there.
